Age Differences in Primary Prevention Implantable Cardioverter‐Defibrillator Use in U.S. Individuals
- 24 August 2011
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (9) , 1589-1595
Abstract
OBJECTIVES: To estimate the potentially inappropriate use of implantable cardioverter‐defibrillator ICDs in older U.S. adults. DESIGN: Retrospective study. SETTING: The National Cardiovascular Data ICD Registry. PARTICIPANTS: Forty‐four thousand eight hundred five individuals in the National Cardiovascular Data's ICD Registry ™ who had received ICDs for primary prevention from January 2006 to December 2008. Individuals with a prior myocardial infarction and ejection fraction less than 30% were included. MEASUREMENTS: Mortality risk was categorized using the Multicenter Automatic Defibrillator Implantation (MADIT) II risk‐stratification system. Low‐risk and very‐high‐risk individuals were considered potentially inappropriate recipients. RESULTS: Of 44,805 individuals, 67% (n=29,893) were aged 65 and older, of whom 51% were aged 75 and older. A significant proportion of ICD recipients had a low risk of death (16%, n=6,969) or very high risk of nonarrhythmic death (8%, n=3,693). Potentially inappropriate ICD use was 10% in those aged 75 and older, much less than in younger groups (40%, P <.001). Although age was associated with a high risk of nonarrhythmic death, its influence was markedly attenuated after adjusting for comorbidities and timing of ICD implantation (odds ratio=1.02, 95% confidence interval=1.02–1.03, P <.001). CONCLUSION: Potentially inappropriate ICD use appears significantly less—and at modest rates—in older Americans than in younger age groups. Overall, almost one‐quarter of individuals may have received ICDs inappropriately based on their risk of death. Physicians appear to be conservatively referring older adults and wisely deferring those with high comorbid burden.Keywords
This publication has 16 references indexed in Scilit:
- Non–Evidence-Based ICD Implantations in the United StatesJAMA, 2011
- Patient and Physician Determinants of Implantable Cardioverter Defibrillator Use in the Heart Failure PopulationCongestive Heart Failure, 2010
- Implantable cardioverter-defibrillator prescription in the elderlyHeart Rhythm, 2009
- Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-DefibrillatorJAMA, 2009
- Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary PreventionCirculation: Cardiovascular Quality and Outcomes, 2009
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001JACC, 2004
- Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated CardiomyopathyNew England Journal of Medicine, 2004
- A contemporary overview of percutaneous coronary interventionsJACC, 2002
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002